: A102149 [ 35264-05-2 ]; 2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid

: A104896 [ 109183-71-3 ]; Boc-Chg-OH

: A1246116 [ 1187224-06-1 ]; (S)-2-((tert-Butoxycarbonyl)amino)-2-(trans-4-methylcyclohexyl)acetic acid

: A126563 [ 70491-05-3 ]; Boc-D-Chg-OH

: A146057 [ 35264-07-4 ]; (tert-Butoxycarbonyl)-L-alloisoleucine

: A185460 [ 204138-23-8 ]; Boc-L-isoleucine hemihydrate

: A185792 [ 109183-72-4 ]; (S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid

: A262384 [ 361442-00-4 ]; Saxagliptin Impurity 23

: A289231 [ 55780-90-0 ]; Boc-D-Allo-Ile-OH

: A490911 [ 1310680-39-7 ]; (R)-2-((tert-Butoxycarbonyl)amino)-3-ethylpentanoic acid

: A506262 [ 1228542-19-5 ]; (S)-2-((tert-Butoxycarbonyl)amino)-2-cycloheptylacetic acid

: A510574 [ 55721-65-8 ]; Boc-D-Ile-OH

: A552906 [ 155905-77-4 ]; Boc-L-cyclobutylglycine

: A617402 [ 361441-97-6 ]; (2S)-2-(Adamantan-1-yl)-2-((tert-butoxycarbonyl)amino)acetic acid

: A828995 [ 35264-04-1 ]; (S)-2-((tert-Butoxycarbonyl)amino)-3-ethylpentanoic acid

: A1018220 [ 745738-13-0 ]; 2-{[(tert-butoxy)carbonyl]amino}-4-hydroxy-4-methylpentanoic acid

: A1028388 [ 1404735-94-9 ]; 2-([(tert-Butoxy)carbonyl]amino)-3-ethylpentanoic acid

: A1036210 [ 1869638-67-4 ]; 2-{[(tert-butoxy)carbonyl]amino}-3,4-dimethylpentanoic acid

: A1036218 [ 182292-07-5 ]; 2-([(tert-Butoxy)carbonyl]amino)-2-(4-methylcyclohexyl)acetic acid

: A1036449 [ 1404689-48-0 ]; 2-([(tert-Butoxy)carbonyl]amino)-3-methylhexanoic acid

: A132455 [ 2390474-63-0 ]; 2-((tert-Butoxycarbonyl)amino)-3-methylpentanoic acid

: A310293 [ 116194-21-9 ]; N-tert-Butoxycarbonyl-DL-isoleucine

: A599957 [ 55780-92-2 ]; Boc-D-Allo-Ile-OH.DCHA

: A649367 [ 336870-02-1 ]; (S)-a-(Boc-amino)-4-hydroxy-cyclohexaneacetic acid

: A677112 [ 1822530-85-7 ]; a-(Boc-amino)-4-hydroxycyclohexaneacetic acid

: A928416 [ 161479-51-2 ]; Boc-D-a-tert-amylglycine

: A929837 [ 1860033-48-2 ]; (R)-2-((tert-Butoxycarbonyl)amino)-2-cycloheptylacetic acid